Syzygium aromaticum Phytoconstituents Target SARS-CoV-2: Integrating Molecular Docking, Dynamics, Pharmacokinetics, and miR-21 rs1292037 Genotyping

Viruses. 2025 Jul 5;17(7):951. doi: 10.3390/v17070951.

Abstract

Background and aim: The COVID-19 pandemic, caused by SARS-CoV-2, remains a global health crisis despite vaccination efforts, necessitating novel therapeutic strategies. Natural compounds from Syzygium aromaticum (clove), such as eugenol and β-caryophyllene, exhibit antiviral and anti-inflammatory properties, while host genetic factors, including miR-21 rs1292037 polymorphism, may influence disease susceptibility and severity. This study investigates the dual approach of targeting SARS-CoV-2 via Syzygium aromaticum phytoconstituents while assessing the role of miR-21 rs1292037 in COVID-19 pathogenesis.

Methods: Firstly, molecular docking and molecular dynamics simulations were employed to assess the binding affinities of eugenol and caryophyllene against seven key SARS-CoV-2 proteins-including Spike-RBD, 3CLpro, and RdRp-using SwissDock (AutoDock Vina) and the Desmond software package, respectively. Secondly, GC-MS was used to characterize the composition of clove extract. Thirdly, pharmacokinetic profiles were predicted using in silico models. Finally, miR-21 rs1292037 genotyping was performed in 100 COVID-19 patients and 100 controls, with cytokine and coagulation markers analyzed.

Results: Docking revealed strong binding of eugenol to viral Envelope Protein (-5.267 kcal/mol) and caryophyllene to RdRp (-6.200 kcal/mol). ADMET profiling indicated favorable absorption and low toxicity. Molecular dynamics simulations confirmed stable binding of methyl eugenol and caryophyllene to SARS-CoV-2 proteins, with caryophyllene-7Z4S showing the highest structural stability, highlighting its strong antiviral potential. Genotyping identified the TC genotype as prevalent in patients (52%), correlating with elevated IL-6 and D-dimer levels (p ≤ 0.01), suggesting a hyperinflammatory phenotype. Males exhibited higher ferritin and D-dimer (p < 0.0001), underscoring sex-based disparities.

Conclusion: The bioactive constituents of Syzygium aromaticum exhibit strong potential as multi-target antivirals, with molecular simulations highlighting caryophyllene's particularly stable interaction with the 7Z4S protein. Methyl eugenol also maintained consistent binding across several SARS-CoV-2 targets. Additionally, the miR-21 rs1292037 polymorphism may influence COVID-19 severity through its role in inflammatory regulation. Together, these results support the combined application of phytochemicals and genetic insights in antiviral research, pending further clinical verification.

Keywords: ADMET; COVID-19; Syzygium aromaticum; caryophyllene; eugenol; genetic polymorphism; inflammatory cytokines; miR-21 rs1292037; molecular docking; molecular dynamics.

MeSH terms

  • Antiviral Agents* / chemistry
  • Antiviral Agents* / pharmacokinetics
  • Antiviral Agents* / pharmacology
  • COVID-19 / virology
  • COVID-19 Drug Treatment*
  • Eugenol / chemistry
  • Eugenol / pharmacokinetics
  • Eugenol / pharmacology
  • Female
  • Genotype
  • Humans
  • Male
  • MicroRNAs* / genetics
  • Middle Aged
  • Molecular Docking Simulation
  • Molecular Dynamics Simulation
  • Phytochemicals* / chemistry
  • Phytochemicals* / pharmacokinetics
  • Phytochemicals* / pharmacology
  • Plant Extracts* / chemistry
  • Plant Extracts* / pharmacokinetics
  • Plant Extracts* / pharmacology
  • Polymorphism, Single Nucleotide
  • SARS-CoV-2* / drug effects
  • SARS-CoV-2* / genetics
  • Spike Glycoprotein, Coronavirus / chemistry
  • Spike Glycoprotein, Coronavirus / metabolism
  • Syzygium* / chemistry

Substances

  • MicroRNAs
  • Antiviral Agents
  • MIRN21 microRNA, human
  • Plant Extracts
  • Phytochemicals
  • Eugenol
  • Spike Glycoprotein, Coronavirus